BUSINESS

• AZ to Shuffle Sales, Marketing Units, Focus on 3 Disease Areas
  June 16, 2014

• Meiji Seika Pharma to Acquire Indian Generic Drug Maker Medreich for US$290 Million
  June 16, 2014

• Ex-Novartis Employee Suspected of Manipulating the Number of Events in Sub-Analysis
  June 13, 2014

• Teijin Now Largest Shareholder of Kyorin Holdings, Owns 19.12% Stake
  June 13, 2014

• Takeda Debuts Aspirin-PPI Combination Drug Takelda in Japan
  June 13, 2014

• Valeant Wins US Approval for Kaken’s Onychomycosis Drug
  June 12, 2014

• Daiichi Sankyo Initiates Development of Novel, Versatile Vaccine Adjuvant
  June 12, 2014

• Nippon Shinyaku to Concentrate Sales Force in Three Therapeutic Fields
  June 11, 2014

• PII Study of Novel AD Treatment Begins in Japan: Fujifilm Holdings
  June 11, 2014

• Novartis Pharma Collects Adverse Events of 10,000 Patients in Wake of Unreported ADRs in SIGN Trial
  June 10, 2014

• Nippon Kayaku to Deploy RA Reps for Remicade Biosimilar
  June 9, 2014

• April Ethical Drug Sales Down 3.5%, Hurt by Pullback from Pre-Tax Hike Demand: Crecon Report
  June 9, 2014

• Results from PI/PII Studies of BBI608, BBI503 Presented at ASCO Annual Meeting: DSP
  June 9, 2014

• AbbVie Can Achieve 100 Billion Yen Sales Target Ahead of Schedule: President
  June 6, 2014

• Malignant STS Treatment Trabectedin Achieves Primary Endpoint in Domestic PII Clinical Trial: Taiho
  June 6, 2014

• Nihon Chouzai to Provide Online Daily Pharmacy Prescription Trend Info.
  June 6, 2014

• Combination Therapy of Avastin, Tarceva Significantly Prolongs PFS in PII Study: Roche
  June 6, 2014

• Sales of 26 Pharma Companies Up 10.3% Driven by Strong Overseas Sales
  June 5, 2014

• Astellas to Issue Monthly EPPV Reports on Suglat for One Year: Product Manager
  June 5, 2014

• Sysmex Inostics, Merck Serono of Germany to Codevelop CoDx for Erbitux for Treatment of Colon Cancer
  June 5, 2014

ページ

• « 先頭
• ‹ Prev
• …
• 552
• 553
• 554
• 555
• 556
• 557
• 558
• 559
• 560
• …
• Next ›
• 最終 »